Sibel Health is a medical technology company spun out of the Querrey Simpson Institute for Bioelectronics at Northwestern University. Headquartered in Niles, IL with an international office in Seoul, South Korea, the firm is backed by a consortium of strategic partner - both for-profit and non-profit. The firm's ANNE® One platform offers a comprehensive physiological monitoring platform with advanced analytics for both clinical care and research applications. Prior to achieving FDA 510(k) clearance, the ANNE® One system has been deployed extensively in thousands of patients across a wide range of geographic locations including low-resource settings with scientific publications in Nature Medicine, Lancet Digital Medicine, and Proceedings of the National Academy of Medicine. Initial focus of the firm's technology in the SBIR arena was sleep apnea. With federal backing, however, Sibel Health subsequently deployed the firm's ANNE®One platform to assess patients with COVID-19. The capacity of the Sibel Inc system to monitor a wide range of vital signs using a dual-sensor platform is powerful. The interoperability and the extendability of the system has the potential to allow its use to expand to other novel indications also make monitoring accessible to a bariader swarch of player
